Elisa Zattarin

Elisa Zattarin

Auto-generated profile, based on publicly available information

Elisa Zattarin

Laboratory of Molecular Materials, Division of Biophysics and Bioengineering, Department of Physics, Chemistry and Biology, Linköping University, SE-581 83, Linköping, Sweden

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2023 in Biomacromolecules
Verified
Journal Article
Open access
Linn BerglundLinn Berglund
Linn Berglund
PSPaula Squinca
Paula Squinca
YBYağmur Baş
Yağmur Baş
EZElisa Zattarin
Elisa Zattarin
DADaniel Aili
Daniel Aili
Kristiina OksmanKristiina Oksman
Kristiina Oksman
The self-assembly of nanocellulose in the form of cellulose nanofibers (CNFs) can be accomplished via hydrogen-bonding assistance into completely bio-based hydrogels. This study aimed to use the intrinsic properties of CNFs, such as their ability to form strong networks and high absorption capacity and exploit them in the sustainable development of effective wound dressing materials. First, TEMPO-oxidized CNFs were separated directly from wood (W-CNFs) and compared with CNFs separated from wood pulp (P-CNFs). Second, two approaches were evaluated for hydrogel self-assembly from W-CNFs, where water was removed from the suspensions via evaporation through suspension casting (SC) or vacuum-assisted filtration (VF). Third, the W-CNF-VF hydrogel was compared to commercial bacterial cellulose (BC). The study demonstrates that the self-assembly via VF of nanocellulose hydrogels from wood was the most promising material as wound dressing and displayed comparable properties to that of BC and strength to that of soft tissue.

30 November 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
AOAbubakr A. M. Omer
Abubakr A. M. Omer
JHJorma Hinkula
Jorma Hinkula
Pham Tue Hung TranPham Tue Hung Tran
Pham Tue Hung Tran
WMWessam Melik
Wessam Melik
EZElisa Zattarin
Elisa Zattarin
HKHazem Khalaf
Hazem Khalaf
Potent broad-spectrum antiviral agents are urgently needed to combat existing and emerging viral infections. This is particularly important considering that vaccine development is a costly and time consuming process and that viruses constantly mutate and render the vaccine ineffective. Antimicrobial peptides (AMP), such as bacteriocins, are attractive candidates as antiviral agents against enveloped viruses. One of these bacteriocins is PLNC8 αβ, which consists of amphipathic peptides with positive net charges that display high affinity for negatively charged pathogen membrane structures, including phosphatidylserine rich lipid membranes of viral envelopes. Due to the morphological and physiological differences between viral envelopes and host cell plasma membranes, PLNC8 αβ is thought to have high safety profile by specifically targeting viral envelopes without effecting host cell membranes. In this study, we have tested the antiviral effects of PLNC8 αβ against the flaviviruses Langat and Kunjin, coronavirus SARS-CoV-2, influenza A virus (IAV), and human immunodeficiency virus-1 (HIV-1). The concentration of PLNC8 αβ that is required to eliminate all the infective virus particles is in the range of nanomolar (nM) to micromolar (μM), which is surprisingly efficient considering the high content of cholesterol (8–35%) in their lipid envelopes. We found that viruses replicating in the endoplasmic reticulum (ER)/Golgi complex, e.g. SARS-CoV-2 and flaviviruses, are considerably more susceptible to PLNC8 αβ, compared to viruses that acquire their lipid envelope from the plasma membrane, such as IAV and HIV-1. Development of novel broad-spectrum antiviral agents can significantly benefit human health by rapidly and efficiently eliminating infectious virions and thereby limit virus dissemination and spreading between individuals. PLNC8 αβ can potentially be developed into an effective and safe antiviral agent that targets the lipid compartments of viral envelopes of extracellular virions, more or less independent of virus antigenic mutations, which faces many antiviral drugs and vaccines.

11 November 2023 in Biomacromolecules
Verified
Journal Article
Open access
YBYağmur Baş
Yağmur Baş
Linn BerglundLinn Berglund
Linn Berglund
TNTotte Niittylä
Totte Niittylä
EZElisa Zattarin
Elisa Zattarin
DADaniel Aili
Daniel Aili
Kristiina OksmanKristiina Oksman
Kristiina Oksman
Hydrogels of cellulose nanofibrils (CNFs) are promising wound dressing candidates due to their biocompatibility, high water absorption, and transparency. Herein, two different commercially available wood species, softwood and hardwood, were subjected to TEMPO-mediated oxidation to proceed with delignification and oxidation in a one-pot process, and thereafter, nanofibrils were isolated using a high-pressure microfluidizer. Furthermore, transparent nanofibril hydrogel networks were prepared by vacuum filtration. Nanofibril properties and network performance correlated with oxidation were investigated and compared with commercially available TEMPO-oxidized pulp nanofibrils and their networks. Softwood nanofibril hydrogel networks exhibited the best mechanical properties, and in vitro toxicological risk assessment showed no detrimental effect for any of the studied hydrogels on human fibroblast or keratinocyte cells. This study demonstrates a straightforward processing route for direct oxidation of different wood species to obtain nanofibril hydrogels for potential use as wound dressings, with softwood having the most potential.

10 April 2025 in Materials Today Bio
Verified
Journal Article
Open access
EZElisa Zattarin
Elisa Zattarin
ZSZeljana Sotra
Zeljana Sotra
EWEmanuel Wiman
Emanuel Wiman
YBYagmur Bas
Yagmur Bas
JRJonathan Rakar
Jonathan Rakar
DADaniel Aili
Daniel Aili
Wounds are highly prone to infection, which can delay healing and lead to severe complications such as gangrene and sepsis. Non-healing wounds significantly impact patients' physical and mental well-being and place a substantial financial burden on healthcare systems. Timely and effective treatment of wound infections is critical, but the rise of antibiotic-resistant pathogens complicates this process. In this study, we investigate a potent protease resistant antimicrobial peptide (AMP), PLNC8 αβ, for the treatment of wound infections and present a strategy for localized AMP delivery using functionalized advanced nanocellulose (NC) wound dressings. Two types of NC dressings were explored: bacterial cellulose (BC) and TEMPO-oxidized nanocellulose derived from wood powder (TC). In a porcine wound infection model, PLNC8 αβ exhibited high antimicrobial activity, successfully eradicating the infection while promoting wound re-epithelialization. To achieve controlled release of PLNC8 αβ from the NC dressings, the peptides were either physisorbed directly onto the nanofibrils or encapsulated within mesoporous silica nanoparticles (MSNs) that were incorporated into the dressings. The PLNC8 αβ functionalized dressings demonstrated low cytotoxicity toward human primary fibroblasts and keratinocytes. Both BC and TC dressings showed efficient contact inhibition of bacteria but were less effective in inhibiting bacteria in suspension. In contrast, MSN-functionalized dressings, displayed significantly enhanced peptide-loading and sustained release capacities, resulting in improved antimicrobial efficacy. These findings highlight the potential of PLNC8 αβ and PLNC8 αβ-functionalized nanocellulose wound dressings for the treatment of infected wounds, offering an effective alternative to conventional antibiotic therapies.

13 January 2026 in ACS Applied Nano Materials
Verified
Journal Article
Open access
WKWasihun Bekele Kebede
Wasihun Bekele Kebede
EZElisa Zattarin
Elisa Zattarin
ZSZeljana Sotra
Zeljana Sotra
EWEmanuel Wiman
Emanuel Wiman
ASAnnika Starkenberg
Annika Starkenberg
DADaniel Aili
Daniel Aili

2 October 2025 in Journal of Colloid and Interface Science
Verified
Journal Article
Open access
VGValentina Guerrero-Florez
Valentina Guerrero-Florez
EZElisa Zattarin
Elisa Zattarin
LKLalit Pramod Khare
Lalit Pramod Khare
EWEmanuel Wiman
Emanuel Wiman
TBTorbjörn Bengtsson
Torbjörn Bengtsson
Emma BjörkEmma Björk
Emma Björk
Mesoporous silica materials are promising carriers for antimicrobial peptides (AMPs), offering a versatile platform for combating bacterial infections. However, achieving high loading efficiency and controlled AMP release under physiological conditions remains a challenge. This study introduces a protein-capped mesoporous silica-based delivery system for treating topical bacterial infections. The system leverages elevated protease activity at infection sites to trigger the release of the sequence-optimized antimicrobial lipopeptide L-6-C5 (SOAP), facilitating efficient bacterial killing. SOAP was loaded into aminopropyl-functionalized SBA-15 mesoporous silica (amino-SBA-15) and capped with bovine serum albumin (BSA) or casein, forming amino-SBA-15-SOAP@protein. Protein adsorption prevented premature SOAP release while enabling protease-triggered delivery. BSA capping achieved 92.6 ± 0.2 % loading efficiency and enhanced peptide retention by 4.5-fold compared to non-capped particles, while casein yielded only a 1.25-fold increase. In the absence of proteases, SOAP release followed first-order kinetics, resulting in sustained release over 6 days. When exposed to trypsin, the release mechanism changed from diffusion-based to anomalous non-Fickian transport with zero-order kinetics, enabling rapid and efficient SOAP release. Proteolytic degradation of the protein cap also accelerated particle degradation and aggregation, offering insights into release dynamics under physiological conditions. The BSA-capped systems (amino-SBA-15-SOAP@BSA) showed effective bacteriostatic activity against Staphylococcus aureus (S. aureus), low hemolytic activity, and high cytocompatibility toward human dermal fibroblasts, outperforming free SOAP. Additionally, BSA capping reduced nonspecific protein binding in serum-rich media. By integrating sustained SOAP delivery with protease-triggered release, the amino-SBA-15-SOAP@BSA system addresses key limitations in AMP delivery, providing a promising strategy for controlled and localized AMP delivery in the treatment of topical bacterial infections.